Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds

Details for Australian Patent Application No. 2003291362 (hide)

International Classifications

Event Publications

8 April 2004 Complete Application Filed

Priority application(s): 60/424,928 08.11.02 US

8 July 2004 Application Open to Public Inspection

Published as AU-B-2003291362

27 November 2008 Alteration of Name

The name of the applicant has been altered to Schering Corporation; Encysive Pharmaceuticals Inc.

15 January 2009 Application Accepted

Published as AU-B-2003291362

22 January 2009 Assignment before Grant

Schering Corporation; Encysive Pharmaceuticals Inc. The application has been assigned to Schering Corporation

14 May 2009 Standard Patent Sealed

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.